| [1] |
Wentao Zhu, Wanglong Hong, Miaomiao Zheng, Guoqiang Ma, Aizong Shen.
Combination of pembrolizumab and chemotherapy as first-line treatment in advanced triple-negative breast cancer: a cost-effectiveness analysis
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 587-597.
|
| [2] |
Dakuan Wang, Bo Peng, Mengmeng Qin, Minghui Li, Ge Song, Bing He, Hua Zhang, Wenbing Dai, Qiang Zhang, Xiangbao Meng, Huan Meng, Xueqing Wang.
Integrated combination delivery of IDO inhibitor and paclitaxel for cancer treatment
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(1): 1-16.
|
| [3] |
Shen Lin, Xin Rao, Yiyuan Li, Xiuhua Weng, Changlian Wang.
Cost-effectiveness analysis of second-line chemotherapy strategies for patients with advanced non-squamous non-small cell lung cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(8): 542-553.
|
| [4] |
Meng Lei, Xueyuan Wang, Hang Miao, Jia Wang, Sijia Sha, Jiang Zhu, Yongqiang Zhu.
Co-delivery of paclitaxel and gemcitabine via folic acid-conjugated polymeric multi-drug nanoparticles (FA-PMDNPs) for the treatment of breast cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 701-710.
|
| [5] |
Yan Lu, Li-Na Liu, Hong-Gang Lou, Xiang Xu*.
Shenfu injection protects against myelosuppression from chemotherapy
[J]. , 2012, 21(4): 345-349.
|
| [6] |
Li Rui, Zhao Haoru*, Lin Yining .
Anti-tumor Effect and Protective Effect on Chemotherapeutic Damage of Water Soluble Extracts from Hedyotis diffusa
[J]. , 2002, 11(2): 54-58.
|
| [7] |
Lu Hongdi, Tang Weixue, Zhou Jianfang.
Analysis of the Combination Chemotherapy Effect In Vitro Utilizing the Median-effect Principle
[J]. , 1999, 8(4): 229-232.
|
>
>